# Symptelligence

> Publicly sourced profile assembled by Optimly, in the Optimly AI Brand Index. Last refreshed 2026-10-04.

- **Business Profile:** https://optimly.ai/brand/symptelligence
- **Dataset:** https://optimly.ai/brand/symptelligence.json
- **Markdown:** https://optimly.ai/brand/symptelligence/llms.txt
- **Official website:** https://symptelligence.com
- **Slug:** symptelligence
- **Categories:** digital-health-telehealth, healthcare-it

## Overview

- **Tagline:** Merges modern technology with an accredited scoring methodology; provides symptom-specific questionnaires, diaries, and remote patient monitoring; proprietary software allows physicians to customize diagnostic and treatment algorithms; offers user-friendly, secure physician portal displaying analyzed, quantitative clinical information; facilitates remote treatment adjustments and supports telehealth reimbursement.
Source: Brand's website (https://symptelligence.com) · 2026-10-04

- **Description:** Symptelligence develops weShare, an mHealth telehealth platform and patient management tool designed to connect physicians, patients, providers, and payers for easier data collection, diagnoses, treatments, and improved outcomes, particularly for Lower Urinary Tract Symptoms (LUTS). It facilitates remote monitoring and data sharing between patients and doctors to enhance care efficiency and effectiveness.
Source: Brand's website (https://symptelligence.com) · 2026-10-04

## Offerings

- **Core capabilities:**
  - weShare (telehealth app
  - patient management platform
  - remote patient monitoring solution)
Source: Brand's website (https://symptelligence.com) · 2026-10-04

## Audience

- **Target industry:** Patients with Lower Urinary Tract Symptoms (LUTS), Physicians (urologists, general practitioners), Healthcare Providers (hospitals, IDNs, HMOs, government providers), Payers (insurance companies).
Source: Brand's website (https://symptelligence.com) · 2026-10-04

Page last updated 2026-10-04.